Amoxapine
Active substance: amoxapine
TABLET · AMOXAPINE 50 mg/1
United StatesActive
Marketing holder: Actavis Pharma, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- AMOXAPINE · 50 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-d479-7979-a349-beae9a30bd9a,01a1208d-c4d6-740b-912b-53e9bc875196,01a1208e-9a73-7686-9460-c79a0a361f12,01a12090-fb9c-71b0-8b89-022775b93180,01a12092-1698-72e2-a4d4-230545990800;count=8 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0591-5714
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0591-5714 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0591-5714 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0591-5714 · Verified 2026-10-09 · open in source